Related references
Note: Only part of the references are listed.Tu1617 The Synthetic Triterpenoid (CDDO-IM) Inhibits STAT3, As Well As IL-17, and Improves DSS-Induced Colitis in Mice
Elizabeth Stonesifer et al.
GASTROENTEROLOGY (2015)
Inhibition of IL-17 as a Pharmacological Approach for IBD
Leo R. Fitzpatrick
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2013)
A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas
David S. Hong et al.
CLINICAL CANCER RESEARCH (2012)
Th17-Related Cytokines in Inflammatory Bowel Diseases: Friends or Foes?
I. Monteleone et al.
CURRENT MOLECULAR MEDICINE (2012)
Inhibition of Pim-1 Kinase Ameliorates Dextran Sodium Sulfate-Induced Colitis in Mice
Yue-Ming Shen et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
IL-6, IL-17 and STAT3: a holy trinity in auto-immunity?
Annalisa Camporeale et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2012)
IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+ Th17 cells
Margherita Coccia et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Vidofludimus Inhibits Colonic Interleukin-17 and Improves Hapten-Induced Colitis in Rats by a Unique Dual Mode of Action
Leo R. Fitzpatrick et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Novel Pharmacological Approaches for Inflammatory Bowel Disease: Targeting Key Intracellular Pathways and the IL-23/IL-17 Axis
Leo R. Fitzpatrick
INTERNATIONAL JOURNAL OF INFLAMMATION (2012)
NF-kappa B and STAT3 - key players in liver inflammation and cancer
Guobin He et al.
CELL RESEARCH (2011)
Triterpenoid modulation of IL-17 and Nrf-2 expression ameliorates neuroinflammation and promotes remyelination in autoimmune encephalomyelitis
Tej K. Pareek et al.
SCIENTIFIC REPORTS (2011)
Synthetic Triterpenoids Prolong Survival in a Transgenic Mouse Model of Pancreatic Cancer
Karen T. Liby et al.
CANCER PREVENTION RESEARCH (2010)
Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
Sergei I. Grivennikov et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
4SC-101, a Novel Immunosuppressive Drug, Inhibits IL-17 and Attenuates Colitis in Two Murine Models of Inflammatory Bowel Disease
Leo R. Fitzpatrick et al.
INFLAMMATORY BOWEL DISEASES (2010)
The Synthetic Triterpenoid, CDDO-Me, Modulates the Proinflammatory Response to In Vivo Lipopolysaccharide Challenge
Jeffery J. Auletta et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)
Interleukin-1 and IL-23 Induce Innate IL-17 Production from γδ T Cells, Amplifying Th17 Responses and Autoimmunity
Caroline E. Sutton et al.
IMMUNITY (2009)
Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation
Melanie A. Kleinschek et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice
Reiko Ito et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
In vitro and in vivo effects of the probiotic Escherichia coli strain M-17:: immunomodulation and attenuation of murine colitis
Leo R. Fitzpatrick et al.
BRITISH JOURNAL OF NUTRITION (2008)
The synthetic triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole blocks nuclear factor-κB activation through direct inhibition of IκB kinase β
Mark M. Yore et al.
MOLECULAR CANCER THERAPEUTICS (2006)
The synthetic triterpenoid CDDO-imidazolide suppresses STAT phosphorylation and induces apoptosis in myeloma and lung cancer cells
Karen Liby et al.
CLINICAL CANCER RESEARCH (2006)
A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis
Caroline Sutton et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole
MS Yates et al.
CANCER RESEARCH (2006)
Share Paper
